Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-13 5:01 pm Purchase | 13G | BIOMARIN PHARMACEUTICAL INC BMRN | VANGUARD GROUP INC | 18,048,557 9.58% | 683,477 (+3.94%) | View |
| 2024-02-13 1:21 pm Sale | 13G | BIOMARIN PHARMACEUTICAL INC BMRN | DODGE & COX | 13,994,063 7.4% | -389,600 (-2.71%) | View |
| 2024-02-12 4:01 pm Purchase | 13G | BIOMARIN PHARMACEUTICAL INC BMRN | PRIMECAP MANAGEMENT CO | 18,414,374 9.78% | 833,515 (+4.74%) | View |
| 2024-02-09 5:46 pm Purchase | 13G | BIOMARIN PHARMACEUTICAL INC BMRN | Capital Research Global Investors | 10,774,641 5.7% | 5,123,640 (+90.67%) | View |
| 2024-01-26 11:49 am Sale | 13G | BIOMARIN PHARMACEUTICAL INC BMRN | BlackRock Inc. BLK | 14,740,836 7.8% | -465,854 (-3.06%) | View |
| 2023-02-14 1:25 pm Sale | 13G | BIOMARIN PHARMACEUTICAL INC BMRN | DODGE & COX | 14,383,663 7.7% | -441,386 (-2.98%) | View |
| 2023-02-13 3:32 pm Sale | 13G | BIOMARIN PHARMACEUTICAL INC BMRN | Capital Research Global Investors | 5,651,001 3% | -7,021,007 (-55.41%) | View |
| 2023-02-09 4:01 pm Sale | 13G | BIOMARIN PHARMACEUTICAL INC BMRN | PRIMECAP MANAGEMENT CO | 17,580,859 9.46% | -223,921 (-1.26%) | View |
| 2023-02-09 11:12 am Purchase | 13G | BIOMARIN PHARMACEUTICAL INC BMRN | VANGUARD GROUP INC | 17,365,080 9.34% | 1,014,049 (+6.20%) | View |
| 2023-02-03 4:27 pm Purchase | 13G | BIOMARIN PHARMACEUTICAL INC BMRN | BlackRock Inc. BLK | 15,206,690 8.2% | 1,185,398 (+8.45%) | View |
| 2022-03-11 2:13 pm Unchanged | 13G | BIOMARIN PHARMACEUTICAL INC BMRN | BlackRock Inc. BLK | 14,021,292 7.6% | 0 (Unchanged) | View |
| 2022-02-14 12:48 pm Purchase | 13G | BIOMARIN PHARMACEUTICAL INC BMRN | DODGE & COX | 14,825,049 8.1% | 5,028,125 (+51.32%) | View |
| 2022-02-10 12:21 pm Sale | 13G | BIOMARIN PHARMACEUTICAL INC BMRN | PRIMECAP MANAGEMENT CO | 17,804,780 9.7% | -400,554 (-2.20%) | View |
| 2022-02-09 3:33 pm Sale | 13G | BIOMARIN PHARMACEUTICAL INC BMRN | VANGUARD GROUP INC | 16,351,031 8.91% | -18,658 (-0.11%) | View |
| 2022-02-08 5:05 pm Sale | 13G | BIOMARIN PHARMACEUTICAL INC BMRN | BlackRock Inc. BLK | 14,021,292 7.6% | -745,600 (-5.05%) | View |
| 2022-01-10 12:04 pm Sale | 13G | BIOMARIN PHARMACEUTICAL INC BMRN | Capital Research Global Investors | 12,672,008 6.9% | -9,521,519 (-42.90%) | View |
| 2021-03-08 11:02 am Purchase | 13G | BIOMARIN PHARMACEUTICAL INC BMRN | PRIMECAP MANAGEMENT CO | 18,205,334 10.03% | 57,373 (+0.32%) | View |
| 2021-02-16 3:58 pm Purchase | 13G | BIOMARIN PHARMACEUTICAL INC BMRN | Capital Research Global Investors | 22,193,527 12.2% | 189,462 (+0.86%) | View |
| 2021-02-11 3:42 pm Purchase | 13G | BIOMARIN PHARMACEUTICAL INC BMRN | DODGE & COX | 9,796,924 5.4% | 9,796,924 (New Position) | View |
| 2021-02-10 10:39 am Sale | 13G | BIOMARIN PHARMACEUTICAL INC BMRN | VANGUARD GROUP INC | 16,369,689 9.02% | -167,091 (-1.01%) | View |